Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
The AAPS Journal
|
September 15, 2012
Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations
Ethan M Stier, Barbara M Davit, Parthapratim Chandaroy, et al.
The AAPS Journal
|
October 12, 2012
Common reasons for "for-cause" inspections in bioequivalence studies submitted to the Food and Drug Administration
Bing V Li, Barbara M Davit, Christina H Lee, et al.
Investigative Ophthalmology & Visual Science
|
June 13, 2015
In Vivo Evaluation of White Matter Integrity and Anterograde Transport in Visual System After Excitotoxic Retinal Injury With Multimodal MRI and OCT
Leon C Ho, Bo Wang, Ian P Conner, et al.
Journal of Pharmaceutical Sciences
|
June 21, 2024
Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal Antibodies
Mark A Bryniarski, Md Tariqul Haque Tuhin, Timothy M Acker, et al.
Scientific Reports
|
October 4, 2019
Widespread brain reorganization perturbs visuomotor coordination in early glaucoma
Vivek Trivedi, Ji Won Bang, Carlos Parra, et al.
Pharmaceutical Research
|
August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensions
Lawrence X Yu, Gordon L Amidon, James E Polli, et al.
Mabs
|
October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
Shufang Liu, Sara C Humphreys, Kevin D Cook, et al.
The AAPS Journal
|
March 12, 2015
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences
Dongmei Lu, Sau L Lee, Robert A Lionberger, et al.
Molecular Pharmaceutics
|
October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development
Mehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal
|
September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration
Barbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
The AAPS Journal
|
September 15, 2012
Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations
Ethan M Stier, Barbara M Davit, Parthapratim Chandaroy, et al.
The AAPS Journal
|
October 12, 2012
Common reasons for "for-cause" inspections in bioequivalence studies submitted to the Food and Drug Administration
Bing V Li, Barbara M Davit, Christina H Lee, et al.
Investigative Ophthalmology & Visual Science
|
June 13, 2015
In Vivo Evaluation of White Matter Integrity and Anterograde Transport in Visual System After Excitotoxic Retinal Injury With Multimodal MRI and OCT
Leon C Ho, Bo Wang, Ian P Conner, et al.
Journal of Pharmaceutical Sciences
|
June 21, 2024
Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal Antibodies
Mark A Bryniarski, Md Tariqul Haque Tuhin, Timothy M Acker, et al.
Scientific Reports
|
October 4, 2019
Widespread brain reorganization perturbs visuomotor coordination in early glaucoma
Vivek Trivedi, Ji Won Bang, Carlos Parra, et al.
Pharmaceutical Research
|
August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensions
Lawrence X Yu, Gordon L Amidon, James E Polli, et al.
Mabs
|
October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
Shufang Liu, Sara C Humphreys, Kevin D Cook, et al.
The AAPS Journal
|
March 12, 2015
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences
Dongmei Lu, Sau L Lee, Robert A Lionberger, et al.
Molecular Pharmaceutics
|
October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development
Mehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal
|
September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration
Barbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Page
of 15